Off-Label Risk Areas on the Internet

Do you engage in social media? Perhaps you do and you don't even realize it? If you're spending several hours on Facebook, then you're probably addicted to social media. Well, the FDA is meeting today and tomorrow to discuss how social media should impact drug promotion. (FDA Public Hearing: Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools)

To that point, there's an upcoming webinar (this one is NOT free) titled, "Off-Label Risk Areas on the Internet – Updates on FDA’s Meeting on On-Line Promotions"

Here's a brief summary of this webinar:

This webinar, provides participants with the opportunity to review current industry practices regards to the complexities of promotional review for online channels and other off-label risk areas on the internet, including discussion surrounding the latest social networking sites and other non-traditional media channels.

Key Questions to Be Addressed:

• What happened at the recent FDA meeting and what if any hard information resulted
• How much listening vs. monitoring and commenting should a company do of user-generated information/social media?
• What are the business reasons for engaging in social media?
• What are the pros and cons of being involved in user-generated content on balance to the risks for off-label discussion and adverse event reporting?

The Center for Business Intelligence has been reviewed and approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET).

To learn more about this event, click here.